News on 6

What to know about Moderna’s new ‘mNexspike’ COVID-19 vaccine

The FDA has approved a new COVID-19 vaccine developed by Moderna, offering a lower-dose option aimed at older adults and people with underlying health risks. The vaccine, named mNexspike, is ...
Hosted on MSN

Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a label narrower than initially targeted. The vaccine will be marketed ...
WTVD

Moderna COVID vaccine performs as well in children as it does in adults, company says

CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...
NBC 10 Philadelphia

FDA grants limited approval to new Covid vaccine from Moderna

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with at least one medical ...
Hosted on MSN

How Moderna Went From Pandemic Hero to Vaccine Victim

Moderna was once a darling of the first Trump administration, which went to great lengths to help the company develop its Covid-19 vaccine that protected millions of people from the virus. Now the ...
NBC Los Angeles

Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot

Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product ...